Skip to main content
69°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about IONS
Recent news which mentions IONS
< Previous
1
2
3
4
5
6
Next >
12 Analysts Have This To Say About Ionis Pharmaceuticals
August 02, 2024
Tickers
IONS
Tags
BZI/AAR
Market News
Analyst Ratings
From
Benzinga
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
July 22, 2024
Tickers
ALNY
AZN
BIIB
IONS
Tags
BIIB
Trading Ideas
why it's moving
From
Benzinga
The Latest Analyst Ratings For Ionis Pharmaceuticals
July 16, 2024
Tickers
IONS
Tags
Benzinga
IONS
BZI/AAR
From
Benzinga
Assessing Ionis Pharmaceuticals: Insights From 6 Financial Analysts
June 27, 2024
Tickers
IONS
Tags
IONS
Benzinga
BZI/AAR
From
Benzinga
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 24, 2024
Tickers
ALNY
ALT
ARGX
CLOV
Tags
Markets
ARGX
RXO
From
Benzinga
Deep Dive Into Ionis Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
June 03, 2024
Tickers
IONS
Tags
IONS
Benzinga
BZI/AAR
From
Benzinga
Ionis Pharmaceuticals Reveals Late-Stage Donidalorsen Data, Analyst Says Results Show Competitive Hereditary Angioedema Profile
May 31, 2024
Tickers
IONS
NEWS
Tags
Market News
Analyst Ratings
Health Care
From
Benzinga
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
May 31, 2024
Tickers
BIIB
IONS
NEWS
Tags
Market News
Health Care
Benzinga
From
Benzinga
Tale Of Two Ionis-Partnered Neurology-Focused Early Stage Assets-Biogen Discontinues One, Decides Not To Exercise Licensing Option For Another
May 16, 2024
Tickers
BIIB
IONS
NEWS
Tags
Movers
General
Equities
From
Benzinga
The 3 Most Undervalued Pharma Stocks to Buy in May 2024
May 09, 2024
Tickers
BIIB
IONS
SNY
Tags
IONS
BIIB
SNY
From
InvestorPlace
The Analyst Landscape: 8 Takes On Ionis Pharmaceuticals
May 08, 2024
Tickers
IONS
Tags
IONS
Benzinga
Market News
From
Benzinga
IONS Stock Earnings: Ionis Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
May 07, 2024
Tickers
IONS
Tags
Earnings Reports
IONS
NASDAQ:IONS
From
InvestorPlace
The Latest Analyst Ratings For Ionis Pharmaceuticals
April 09, 2024
Tickers
IONS
Tags
IONS
Benzinga
Market News
From
Benzinga
Genetic Medicines Focused-Ionis Pharmaceuticals' Fatty Liver Candidate Lowers Excess Liver Fat, Midstage Study Data Shows
March 13, 2024
Tickers
IONS
NEWS
Tags
Market News
Health Care
Biotech
From
Benzinga
Cracking The Code: Understanding Analyst Reviews For Ionis Pharmaceuticals
February 22, 2024
Tickers
IONS
Tags
Benzinga
IONS
Analyst Ratings
From
Benzinga
Earnings Scheduled For February 21, 2024
February 21, 2024
Tickers
ACVA
ADI
AGI
AGR
Tags
AVA
UTHR
PUMP
From
Benzinga
JP Morgan Maintains Neutral Rating for Ionis Pharmaceuticals: Here's What You Need To Know
February 01, 2024
Tickers
IONS
Tags
IONS
Benzinga
BZI/AAR/UPDATE
From
Benzinga
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
January 31, 2024
Tickers
BIIB
IONS
NEWS
Tags
Market News
Alzheimer's disease
Health Care
From
Benzinga
Rare Disease Focused Ionis Pharmaceuticals Gears Up for FDA Submission After Donidalorsen Outperforms Placebo In Swollen Vessels Study
January 22, 2024
Tickers
IONS
NEWS
Tags
Analyst Color
Expert Ideas
Equities
From
Benzinga
Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 8 Analysts
January 18, 2024
Tickers
IONS
Tags
IONS
Benzinga
Analyst Ratings
From
Benzinga
2024 And Beyond – Exploring Six Investment Megatrends With Tema ETFs
January 04, 2024
Tickers
ALNY
ARM
CPRI
IONS
Tags
MRK
ALNY
TPR
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 02, 2024
Tickers
ABBV
ALNY
CVS
GILD
Tags
IMGN
ABBV
LLY
From
Benzinga
3 Stocks to Buy Now Before They Become Tomorrow’s Trillion-Dollar Companies
December 27, 2023
Tickers
IONS
TSM
UNH
Tags
NASDAQ:IONS,NYSE:UNH,NYSE:TSM
IONS
TSM
From
InvestorPlace
Pricing Projections And Market Potential For Ionis' Newly Approved Nerve Damage Drug - Analyst Sees Over $700M Potential
December 22, 2023
Tickers
ALNY
AZN
IONS
NEWS
Tags
Trading Ideas
IONS
Briefs
From
Benzinga
New Hope for Nerve Damage Patients as AstraZeneca/Ionis' Eplontersen Receives FDA Nod for Hereditary Amyloidosis Treatment
December 22, 2023
Tickers
AZN
IONS
NEWS
Tags
FDA
Market News
Benzinga
From
Benzinga
Ionis' Strategic Shift Praised by Analysts For Donidalorsen's Global Reach
December 19, 2023
Tickers
IONS
TAK
Tags
Trading Ideas
News
IONS
From
Benzinga
Where Ionis Pharmaceuticals Stands With Analysts
November 17, 2023
Tickers
IONS
Tags
Benzinga
IONS
BZI/AAR
From
Benzinga
Cathie Wood's Ark Invest Goes Shopping For Moderna Stock — Sells DraftKings Shares Amid Quarterly Rise In Revenue, EPS Beat
November 02, 2023
Tickers
ARKG
ARKK
ARKQ
DKNG
Tags
NVDA
Moderna
ETFs
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
October 23, 2023
Tickers
IONS
Tags
Benzinga
IONS
Market News
From
Benzinga
Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
October 17, 2023
Tickers
ARKG
ARKK
CRSP
EVS
Tags
EVs
News
Tesla
From
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.